Related Experiment Video

Updated: Jun 28, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Lipid disorders in chronic kidney disease: reverse epidemiology and therapeutic approach

Michal Chmielewski1, Juan Jesus Carrero, Louise Nordfors

  • 1Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm - Sweden.

Journal of Nephrology
|October 25, 2008
PubMed

Insights

Dyslipidemia, common in the general population, has a complex relationship with mortality in chronic kidney disease (CKD) patients. This review explores lipid disorders in CKD, genetic factors, and therapies, including novel approaches to understand cholesterol

Area of Science:

  • Nephrology
  • Cardiology
  • Metabolic Disorders

Background:

  • Dyslipidemia is a known cardiovascular risk factor in the general population.
  • The association between dyslipidemia and mortality in chronic kidney disease (CKD) is complex and often paradoxical, with low cholesterol sometimes predicting mortality.

Purpose of the Study:

  • To review major lipid metabolism disorders in CKD patients.
  • To discuss the clinical implications of dyslipidemia in CKD.
  • To explore genetic factors and current therapeutic strategies for dyslipidemia in CKD.

Main Methods:

  • Literature review of dyslipidemia in chronic kidney disease.
  • Discussion of genetic determinants of dyslipidemia.
  • Exploration of current and novel therapeutic approaches, including mendelian randomization.

Main Results:

  • CKD is associated with significant alterations in lipid metabolism.
  • The relationship between cholesterol levels and mortality in CKD is inverse compared to the general population.
  • Genetic factors and specific therapeutic interventions play a role in managing dyslipidemia in CKD.

Conclusions:

  • Understanding the unique lipid profiles and their implications in CKD is crucial for patient management.
  • Novel approaches like mendelian randomization are needed to clarify the paradoxical association between hypercholesterolemia and mortality in CKD.
  • Further research into genetic predispositions and targeted therapies is essential for improving outcomes in CKD patients with dyslipidemia.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...